HealthStream (HSTM) Director Linda Rebrovick Sells $420K of Stock

HealthStream, Inc. director Linda Rebrovick sold 12,000 shares of the company's stock on October 23, 2026, at a price of $35.00 per share. The transaction was disclosed in a Form 4 filing with the Securities and Exchange Commission.

HSTM HealthStream, Inc.

$35.16 ▲ +54.96% year to date

1M 3M YTD

Daily close · Oct 23, 2026

Inside Linda Rebrovick's HealthStream Trade

The planned sale totaled $420,000 and reduced Rebrovick's direct share ownership by a 23.38% margin. Following the transaction, she holds 39,329 shares of HealthStream stock. This follows several earlier sales by Rebrovick, including two separate sales of 2,000 shares each in May and June 2026, and 6,000 shares in July 2026.

Other Institutional Activity in HealthStream

Copeland Capital Management, LLC trimmed its holdings by 31,211 shares for a 2.5% decrease, ending with 1,217,236 shares worth about $42,798,017 as of September 30, 2026. Two Sigma Investments, LP reduced its stake by 38,844 shares, marking a 4.6% decrease to finish with 805,584 shares valued at roughly $28,324,333 as of June 30, 2026.

HealthStream, Inc. Stock Up 4.9%

The shares recently traded around $35.16, sitting above their 50-day moving average of $30.26 and well above the 200-day moving average of $25.22. The stock trades near its 52-week high of $34.67, representing a sharp move up from its 52-week low of $19.50.

Recent Earnings

For the trailing twelve months, the company reported revenue of $321,118,016 with earnings of $0.74 per share. HealthStream generated a net profit margin of 6.6% alongside a return on equity of 6.0%. The company is scheduled to release its next financial results on November 2, 2026.

Dividend

The company pays an annual dividend rate of $0.14 per share, translating to a dividend yield of 0.39% with a payout ratio of 18.3%.

Insider Buying and Selling at HealthStream, Inc.

Earlier insider moves include Chief Executive Officer Robert A. Frist Jr. selling 144,068 shares at $29.50 each on September 14, 2026, for a total value of $4,250,006. Director Linda Rebrovick also sold 2,000 shares at $25.00 on May 28, 2026, for $50,000, 2,000 shares at $25.00 on June 1, 2026, for $50,000, and 6,000 shares at $29.00 on July 6, 2026, for $174,000.

Analysts Set New Price Targets

On July 21, 2026, Canaccord Genuity maintained a hold rating on the stock while raising its price target to $27.00 from $24.00. Later, on October 13, 2026, Freedom Capital Markets initiated coverage on the stock with a hold rating and a $36.00 price target. The stock holds a consensus recommendation of buy with a mean price target of $35.00 across three analyst opinions.

About HealthStream

Headquartered in Nashville, Tennessee, HealthStream provides software-as-a-service applications tailored for healthcare organizations across the United States. The company helps hospitals and medical providers manage workforce development, credentialing, and provider training.

Bottom Line

Investors will look toward the upcoming earnings report on November 2, 2026, for further insight into the provider's financial performance. Future SEC filings will provide additional details on executive and director transactions.